Back
Teva Pharmaceutical Industries 10K Form
Sell
21
TEVA
Teva Pharmaceutical Industries
Last Price:
$13.88
Seasonality Move:
1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2024-02-12 | 10K | TEVA/Teva Pharmaceutical Industries Annual |
| 2023-11-09 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-08-02 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-05-10 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-02-10 | 10K | TEVA/Teva Pharmaceutical Industries Annual |
Receive TEVA News And Ratings
See the #1 stock for the next 7 days that we like better than TEVA
TEVA Financial Statistics
Sales & Book Value
| Annual Sales: | $16.5B |
|---|---|
| Cash Flow: | $446M |
| Price / Cash Flow: | 20.09 |
| Annual Sales: | $4.74 |
| Price / Book: | 2.84 |
Profitability
| EPS (TTM): | -1.45000 |
|---|---|
| Net Income (TTM): | $-1.6B |
| Gross Margin: | $8.1B |
| Return on Equity: | -23.87% |
| Return on Assets: | -3.93% |
Teva Pharmaceutical Industries Earnings Forecast
Key Teva Pharmaceutical Industries Financial Ratios
-
The Gross Profit Margin over the past 39 years for TEVA is 48.74%.
-
The Selling, General & Administrative Expenses for TEVA have been equal to 22.38% of Gross Profit Margin.
-
The Research & Development expenses have been 6.03% of Revenue.
-
The Net Earning history of TEVA is -9.91% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 24 years.
Teva Pharmaceutical Industries Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TEVA |
| CUSIP: | 881624 |
| Website: | tevapharm.com |
Debt
| Debt-to-Equity Ratio: | 3.31 |
|---|---|
| Current Ratio: | 0.98 |
| Quick Ratio: | 0.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 4.91 |
TEVA Technical Analysis vs Fundamental Analysis
Sell
21
Teva Pharmaceutical Industries (TEVA)
is a Sell
Is Teva Pharmaceutical Industries a Buy or a Sell?
-
Teva Pharmaceutical Industries stock is rated a SellThe current Teva Pharmaceutical Industries [TEVA] share price is $13.31. The Score for TEVA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.